WHO ICTRP trial
A Clinical Trial to test how well two drugs, QAW039 and Montelukast work both…
EUCTR2012-001389-14-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2012-001389-14-DE |
|---|---|
| Public title | A Clinical Trial to test how well two drugs, QAW039 and Montelukast work both individually and together, to target allergic rhinitis using an environmental exposure chamber. |
| Scientific title | A randomized, double-blind, placebo-controlled three-period incomplete cross over study to compare the efficacy of QAW039 alone and in combination with Montelukast in patients with allergic rhinitis using an Environmental Exposure Chamber - comparison of efficacy of QAW039 alone and with Montelukast… |
| Primary sponsor | Novartis Pharma Services AG |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany |
| Conditions | allergic rhinitis MedDRA version: 15.0 Level: LLT Classification code 10001723 Term: Allergic rhinitis System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders ;Therapeutic area: Diseases [C] - Respiratory Tract… |
| Interventions | Product Code: QAW039 Pharmaceutical Form: Capsule, hard INN or Proposed INN: Not established CAS Number: 872365-14-5 Current Sponsor code: QAW039 Other descriptive name: QAW039-NXA.001 Concentration unit: mg milligram(s) Concentration type… |
| Registration date | Aug 27, 2012 |
| Secondary IDs | CQAW039A2212 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: